Long-Term Follow-up of Patients Treated With Miltenyi Cell and Gene Therapies
Status: Recruiting
Location: See all (7) locations...
Intervention Type: Biological
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
The goal of this Long-Term Follow-Up Trial is to assess long-term safety and efficacy of Miltenyi CAR T treatment.
Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:
• Patient underwent treatment with a Miltenyi CAR T cell therapy in one of the parent trials at least 12 months prior to enrollment in long-term follow-up.
• Patient has provided informed consent prior to enrollment.
Locations
Other Locations
Germany
Charité Universitätsmedizin Berlin
RECRUITING
Berlin
Universitätsklinikum Köln
ACTIVE_NOT_RECRUITING
Cologne
Uniklinikum Erlangen
ACTIVE_NOT_RECRUITING
Erlangen
Universitätsmedizin Göttingen
ACTIVE_NOT_RECRUITING
Göttingen
Universitätsklinikum Münster
RECRUITING
Münster
Universitätsklinikum Tübingen
ACTIVE_NOT_RECRUITING
Tübingen
Universitäts-Kinderklinik Würzburg
ACTIVE_NOT_RECRUITING
Würzburg
Contact Information
Primary
Clinical Trial Manager
clinicaltrials.gov@miltenyi.com
+4922048306820
Time Frame
Start Date: 2024-05-05
Estimated Completion Date: 2040-12-31
Participants
Target number of participants: 40
Treatments
Experimental: Long-term follow-up of CAR T cell therapy
Assessment of long-term safety and efficacy of Miltenyi CAR T treatment.
Related Therapeutic Areas
Sponsors
Leads: Miltenyi Biomedicine GmbH